TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 11 | 12 | 26 | 9 | 186 | 117 | 60 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/20/13 17:33 | 8/15/13 | RTRX | Retrophin, Inc. | OK | Health | Drug | Pharmaceutical Preparations | Panoff Marc L | NY | O | CFO | P.d | 5 | 4.50 | 0 | 1 | 1 | 121 | D | 30 | -11 | 14 | -5 | 14 | 14 | 11 | 12 | 26 | 9 | 186 | 117 | ||
12/4/06 12:04 | 11/30/06 | NRGX | Neurologix Inc/de | DE | Health | Drug | Pharmaceutical Preparations | Panoff Marc L | NJ | O | VP,CFO | P | 8 | 0.7500 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |